Sanfe has raised $1 million in its Series A round from LetsVenture, Ajay Garg, and more
Sanfe, feminine hygiene and intimate skincare brand, has raised $1 million in its Series A round from LetsVenture, Ajay Garg, Tarun Sharma, Arjun Vaidya and Dhimant Parekh among other D2C originators. According to the New Delhi-based startup, the assets will be utilized to expand its essence to new
Sanfe, feminine hygiene and intimate skincare brand, has raised $1 million in its Series A round from LetsVenture, Ajay Garg, Tarun Sharma, Arjun Vaidya and Dhimant Parekh among other D2C originators.
According to the New Delhi-based startup, the assets will be utilized to expand its essence to new markets and to introduce new product offerings.
Established by Archit Aggarwal and Harry Sehrawat, Sanfe creates items like stand-and-pee gadgets, intimate care items, panty liners, organic sanitary pads, pain alleviation roll-ons and menstrual cups.
The startup claims to have an active local area of more than 5 million clients with more than 25% development on a month-on-month basis. Its portfolio also includes body grooming items like facial razors, body razors, and clippers.
Earlier in Feb 2020, it had raised around $1 million in its pre-Series A round from a grasp of investors like SucSEED Venture Partners, Titan Capital, BIRAC, Elixir Pharma and individuals.
Reader questions.
About “Sanfe has raised $1 million in its Series A round from LetsVenture, Ajay Garg, and more” — five of the most-asked, in the desk's own words.
01What is this story about?
Sanfe, feminine hygiene and intimate skincare brand, has raised $1 million in its Series A round from LetsVenture, Ajay Garg, Tarun Sharma, Arjun Vaidya and Dhimant Parekh among other D2C originators. According to the New Delhi-based startup, the assets will be utilized to expand its essence to new02Who wrote it?
Sheena · Staff. 1 min read · Sep 27, 2021.03Is this sponsored?
If a piece is, the disclosure sits above the cover image and again in our public transparency report. This one carries no commercial disclosure.04How do I get the rest?
Subscribe to The Briefing for a Wednesday letter from the desk, or browse by category from the top navigation.
